1-3 of 3
Masato Murakami, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The MDM2 Inhibitor NVP-CGM097 Is Highly Active in a Randomized Preclinical Trial of B-Cell Acute Lymphoblastic Leukemia Patient Derived Xenografts

Elizabeth C Townsend, PhD, Tiffany DeSouza, B.S., Mark A. Murakami, MD MA, Joan Montero, PhD, Kristen Stevenson, MS, Amanda L Christie, B.S., Alexandra N Christodolou, M.Sc., Una Vojinovic, B.S., Nadja Kopp, M.S., Patrizia Barzaghi-Rinaudo, Masato Murakami, MD, PhD, Anthony Letai, MD PhD, Sebastien Jeay, Jens Wuerthner, Ensar Halilovic, David M. Weinstock
Journal: Blood
Blood (2015) 126 (23): 797.
https://doi.org/10.1182/blood.V126.23.797.797
Published: 2015
Journal Articles

Improved Efficacy Upon Combined JAK1/2 and Pan-Deacetylase Inhibition Using Ruxolitinib (INC424) and Panobinostat (LBH589) in Preclinical Mouse Models of JAK2 V617F-Driven Disease

Fabienne Baffert, Emeline Evrot, M.S., Nicolas Ebel, M.S., Claudia Roelli, Rita Andraos, M.S., Zhiyan Qian, M.S., Vincent Romanet, MSc, Masato Murakami, MD, PhD, Thomas Radimerski, PhD
Journal: Blood
Blood (2011) 118 (21): 798.
https://doi.org/10.1182/blood.V118.21.798.798
Published: 2011
Journal Articles

HSP90 Inhibition Targets JAK2 and Is Highly Effective in CRLF2-Rearranged Acute Lymphoblastic Leukemia

Oliver Weigert, MD, Liat Bird, Nadja Kopp, Andrew A. Lane, MD, PhD, Bjoern Chapuy, MD, PhD, Diederik van Bodegom, Sachie Marubayashi, Akinori Yoda, PhD, Vincent Romanet, MSc, Masato Murakami, MD, PhD, Stephen E. Sallan, MD, Ross L Levine, MD, Andrew L. Kung, MD, PhD, Thomas Radimerski, PhD, David M Weinstock, MD
Journal: Blood
Blood (2011) 118 (21): 576.
https://doi.org/10.1182/blood.V118.21.576.576
Published: 2011